NXL Nexalin Technology: Bathi saben saham sajrone rolas wulan pungkasan

Simbol resmi perusahaan Nexalin Technology, Inc. (NXL)

Nexalin Technology, Inc. (NXL) is developing HALO neurostimulation systems in collaboration with clinics to combat depression without medication. The measurement of annual EPS TTM growth visualizes profit dynamics, where the value 23.30 serves as the baseline indicator. However, slow physician adoption and regulatory barriers create risks, while liquidity shortages amid low sales force the company to rely on external capital.

NXL Nexalin Technology Inc: Bathi saben saham sajrone rolas wulan pungkasan ing interval 11.02.2024 - 16.11.2026

Rincian metrik keuangan lan pasar Nexalin (NXL)

- kuotasi saiki lan rata-rata prakiraan nilai:
- data kapitalisasi saham perusahaan:
Pambiji fundamental perusahaan:NXL, Nexalin Technology Inc
Sampel barang Nexalin Technology Inc

Analyzing the rolling year-over-year EPS chart allows for an assessment of the financial viability of Nexalin Technology, Inc. (NXL) given its high dependence on a single neurostimulation segment. This indicator calculates the daily ratio of current annual earnings per share to the previous year's, enabling investors to track value creation dynamics and business resilience as clinical trials expand in the US and China.